Impact of Lymphocyte Anti-metabolite Immunosuppressions on Donor-Specific Anti-HLA Antibody and Kidney Graft Outcome
Clinical trial NCT03794492 · COMPLETED
Trial details
- NCT number
- NCT03794492
- Sponsor
- Chong Kun Dang Pharmaceutical
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-31
- Primary completion
- 2022-07-22
- Enrollment
- 169
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.